Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Alberta

$41,000.00

Functionalized nanomaterial strategies for extracellular vesicle isolation and characterization

FY 2024-25

Summary
Exosomes are extremely small (30-100 nm diameter) lipid bilayer-enclosed extracellular vesicles that facilitate communication between cells proximally (within the same tissue) or distally (ex: gut to brain). Exosomes are secreted by most cell types and carry lipids, proteins and nucleic acids to recipient cells. The potential to modify the biological function of a recipient cell by exosomal shuttling is particularly attractive as a therapeutic technology. There are two main advantages to exosome-mediated delivery of cargo; (i) exosomes protect the lipids, proteins and nucleic acids from degradation, and (ii) exosomes specifically target specific recipient cells and manipulate their function. These unique properties of exosomes provide opportunities for innovations in diagnosis and treatments, yet our understanding of exosomes is limited by inefficient separation methods, lack of exclusive biomarkers, and lack of high-resolution visualization techniques. Previous strategies to directly load exosomes with protein cargo have had significant challenges which has limited their use in in vivo applications. Instead, the direct engineering of parent cells to achieve in situ synthesis and loading of desired proteins into exosomes, which are then secreted, is a more viable option. Exosomes express Rab5, Rab27 and Rab35, and tetraspanins (mainly CD9, CD63 and CD81). We hypothesize that the N- and C-termini of the tetraspanins, which extend into the exosome lumen, are ideal sites to which fusion proteins can be attached. Here we propose, as proof of concept, to use the CD81 tetraspanin protein as a molecular scaffold to express (i) human ?-thrombin as an affinity purification tag within its EC2 loop, and (ii) a receptor that can specifically target and bind inflamed epithelium (aim 1.1). Our donor cells will be mast cells, tissue immune cells. Mast cells are central in innate immunity and tissue remodeling and they release exosomes in response to inflammatory stimuli, making them ideal donor cells in our inflammation target model system in aim 1.2. Lastly, we will develop a novel nanobubble-based filtration system for exosome purification and characterization in aim 2, which will be integrated into the filtration workflow (see figure in appendix), providing unprecedented versatility in biomarker and cargo analysis. My proposed discovery grant program is a prime example of curiosity-driven research that NSERC is designed to support. The foundation of this basic research will develop novel insight on exosome biology. My research will likely reveal the tremendous potential of cell-based custom exosome fabrication as a novel approach for target cargo delivery in vivo. This Canadian research program on exosome production will provide equitable training opportunities for numerous HQPs from diverse backgrounds in the field of nanobiology across two outstanding academic institutions through further development of NRC-UofA collaborations.
Program
Discovery Grants Program - Individual
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2024-05947
Name nom
Kulka, Marianna
Department département
Biomedical Nanotechnologies
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
5102
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Inter-cellular communication
Research subject fr
Communication inter-cellulaire
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Functionalized nanomaterial strategies for extracellular vesicle isolation and characterization
Keywords
extracellular vesicles; microfluidics; drug delivery; lipid nanoparticles; nanobubbles; inflammation; tangential flow filtration; cellular metabolism; proteomics; nmr
Application summary
Exosomes are extremely small (30-100 nm diameter) lipid bilayer-enclosed extracellular vesicles that facilitate communication between cells proximally (within the same tissue) or distally (ex: gut to brain). Exosomes are secreted by most cell types and carry lipids, proteins and nucleic acids to recipient cells. The potential to modify the biological function of a recipient cell by exosomal shuttling is particularly attractive as a therapeutic technology. There are two main advantages to exosome-mediated delivery of cargo; (i) exosomes protect the lipids, proteins and nucleic acids from degradation, and (ii) exosomes specifically target specific recipient cells and manipulate their function. These unique properties of exosomes provide opportunities for innovations in diagnosis and treatments, yet our understanding of exosomes is limited by inefficient separation methods, lack of exclusive biomarkers, and lack of high-resolution visualization techniques. Previous strategies to directly load exosomes with protein cargo have had significant challenges which has limited their use in in vivo applications. Instead, the direct engineering of parent cells to achieve in situ synthesis and loading of desired proteins into exosomes, which are then secreted, is a more viable option. Exosomes express Rab5, Rab27 and Rab35, and tetraspanins (mainly CD9, CD63 and CD81). We hypothesize that the N- and C-termini of the tetraspanins, which extend into the exosome lumen, are ideal sites to which fusion proteins can be attached. Here we propose, as proof of concept, to use the CD81 tetraspanin protein as a molecular scaffold to express (i) human ?-thrombin as an affinity purification tag within its EC2 loop, and (ii) a receptor that can specifically target and bind inflamed epithelium (aim 1.1). Our donor cells will be mast cells, tissue immune cells. Mast cells are central in innate immunity and tissue remodeling and they release exosomes in response to inflammatory stimuli, making them ideal donor cells in our inflammation target model system in aim 1.2. Lastly, we will develop a novel nanobubble-based filtration system for exosome purification and characterization in aim 2, which will be integrated into the filtration workflow (see figure in appendix), providing unprecedented versatility in biomarker and cargo analysis. My proposed discovery grant program is a prime example of curiosity-driven research that NSERC is designed to support. The foundation of this basic research will develop novel insight on exosome biology. My research will likely reveal the tremendous potential of cell-based custom exosome fabrication as a novel approach for target cargo delivery in vivo. This Canadian research program on exosome production will provide equitable training opportunities for numerous HQPs from diverse backgrounds in the field of nanobiology across two outstanding academic institutions through further development of NRC-UofA collaborations.